While research is ongoing to stop the COVID-19 pandemic from spreading even further through the development of vaccines and the presence of antibodies, recent scientific studies suggest that the existence of older coronaviruses may trigger an immune response from the body.

Read more: Passive antibody treatment for COVID-19

Since the first cases of the new coronavirus infection emerged in late 2019, the COVID-19 pandemic has spread to almost all parts of the world, infecting more than 20 million people and leaving more than 736,000 people dead as of 11 August 2020.

But now, various research studies have suggested that people who may have never been exposed to the infection even in the past, may have immunity against the SARS-CoV-2 virus. And various estimates suggest that as many as 20% to 50% of people may have the presence of T cells that can identify the new virus, which belongs to the family of already known coronaviruses.

Four coronaviruses are also sources of the common cold in people, which the human body can identify through the presence of T cells in the bloodstream. Because the coronaviruses are similar to the SARS-CoV-2 virus, the immune system of the body can recognise it and launch an immune response against it.

  1. T cells and COVID-19
  2. Memory T cells return to identify new infections

T cells are a type of white blood cells that are present in the human immune system—they are also known as T lymphocytes. They play a central role in the body's immune response against all kinds of pathogens: viruses, bacteria, parasites.

Read more: Role of T cells in COVID-19 immunity

T cells can be of many types, and they are responsible for identifying the infection-causing virus as well as replacing or repairing already infected cells in the body. They also play a key role in developing antibodies by sending signals to the body to make them when there is an infection taking over.

T cells play a critical role in the different kinds of immune responses—they have had an impact on how different individuals' immune system has responded to SARS-CoV-2 too. SARS-CoV-2 is a virus—it causes COVID-19. However, researchers are still trying to find out exactly what kind of role they play against the new pathogen.

Read more: Study links muscle mass to a strong immune system

T cells also have the capability to fight off infection and kill pathogens even before the body makes or summons antibodies.

myUpchar doctors after many years of research have created myUpchar Ayurveda Urjas Capsule by using 100% original and pure herbs of Ayurveda. This ayurvedic medicine has been recommended by our doctors to lakhs of people for sex problems with good results.
Long Time Capsule
₹712  ₹799  10% OFF
BUY NOW

Several studies have shown that once our T cells have been exposed to a pathogen, they can respond to infections and strains that are closely linked to that original pathogen.

They can be called upon to battle different strains of viruses that cause the flu, for example. They can also be effective against viruses of the same family, like the dengue virus and Zika virus (Zika fever) which are from the same family.

This means if you've ever had dengue fever, then that exposure would have primed your T cells to battle Zika virus, too. (Of course, there is no guarantee that the defence that the T cells mount will be enough to protect you entirely, but will be good enough to give you a running start against the pathogen.)

The same is true for coronaviruses also.

A study published in the scientific journal Nature in July 2020 found that CD4 and CD8 T cells were not only present in the bodies of people who had had a cold because of a coronavirus, but their T cells were also able to identify the SARS-CoV-2 virus if it entered their body.

In fact, the study also found that patients who had recovered from severe acute respiratory disease (SARS)—which caused an outbreak in 2002-03—also had memory T cells for coronaviruses present in their bodies, 17 years on.

Read more: After ACE2, NRP1 emerges as another pathway for COVID-19

However, the study went on to add that it wasn't only the patients who had either recovered from SARS or those who were infected with COVID-19 that had memory T cells present in their systems. Donors who were part of the study and had never contracted either infection, nor had they come into contact with any SARS or COVID-19 patient, also had SARS-CoV-2 specific T cells present in their systems.

Further, the uninfected donors in the study had a different immune response than COVID-19 patients—their T cells were identifying other, related coronaviruses that cause the common cold or beta-coronaviruses which cause SARS and MERS (and now COVID-19). While the researchers deduced that it is the presence of these specific T cells that can protect people against COVID-19, it is still unknown how these T cells help some people to avoid COVID-19 infection.

Read more: Cytokine storm

Another study published in the journal Cell in June 2020 also detected the CD4 cells (CD4 test) in about 40% to 60% of people who had never been exposed to COVID-19, also suggesting that specific T cells are already present in response to common cold-causing coronaviruses.

Another study published in the journal Science this month also suggests that T cells that are routinely called upon by the body's immune system to protect against common cold-causing coronaviruses are also able to identify the SARS-CoV-2 virus through memory.

All the above-mentioned studies are in line with research that has been ongoing to find out about lasting immunity to COVID-19 around the world, but the findings remain hypothetical until concrete evidence linking T cell responses to older coronaviruses is firmly established.


Medicines / Products that contain Immune system can identify COVID-19 because of common cold-causing coronaviruses

Read on app